content/02.introduction.md:145:infodemics
content/20.treatments.md:335:DSHEA
content/20.treatments.md:338:labelling
content/20.treatments.md:339:EFSA
content/20.treatments.md:340:EFSA
content/20.treatments.md:362:phagocytosis
content/20.treatments.md:364:hypothesised
content/20.treatments.md:369:antithrombotic
content/20.treatments.md:369:prothrombotic
content/20.treatments.md:370:antiplatelet
content/20.treatments.md:371:antiplatelet
content/20.treatments.md:371:investigational
content/20.treatments.md:372:antiplatelet
content/20.treatments.md:459:dimorphism
content/20.treatments.md:461:Biobank
content/20.treatments.md:462:Biobank
